Related Experiment Video
Updated: Aug 10, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
A Kantian claim permitting the randomised clinical trial
1University of Virginia, USA.
Princeton Journal of Bioethics
|August 9, 2002
Summary
Randomized clinical trials (RCTs) are ethically debated. This paper demonstrates that RCTs are ethically permissible within a deontological framework, despite common Kantian objections.
Area of Science:
- Medical ethics
- Clinical research methodology
- Philosophy of science
Background:
- Randomized clinical trials (RCTs) are a cornerstone of medical research.
- Ethical justifications for RCTs often rely on utilitarian principles.
- Kantian ethics, emphasizing duties and rules, presents a challenge to RCT methodology.
Purpose of the Study:
- To analyze the ethical permissibility of randomized clinical trials (RCTs) within a deontological framework.
- To address Kantian objections to the use of RCTs in medical research.
- To reconcile RCT methodology with deontological ethical principles.
Main Methods:
- Philosophical analysis of ethical frameworks, specifically utilitarianism and deontology.
- Examination of core Kantian ethical principles (e.g., categorical imperative).
- Argumentative reasoning to demonstrate the compatibility of RCTs with deontology.
Main Results:
- The paper argues that RCTs can be structured to align with deontological requirements.
- Key Kantian principles do not inherently prohibit the use of RCTs.
- Ethical objections based on deontology can be overcome through careful study design and justification.
Conclusions:
- Randomized clinical trials are ethically permissible under a deontological framework.
- The perceived conflict between RCTs and Kantian ethics is resolvable.
- This finding supports the continued use of RCTs in medical research while adhering to ethical duties.
More Related Videos
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
04:11A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
Published on: June 9, 2026
Related Concept Videos
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...